Indian markets witnessed profit taking on Monday after hitting fresh record highs. Benchmark indices pared gains to close flat but with a positive bias.The S&P BSE Sensex touched a high of 81,908 while the Nifty50 hit a record high of 24,999. Market Summary

Technical Breakout Stocks: How to trade FDC, Bandhan Bank and Tata Motors on Tuesday? - Market Summary

FDC Ltd notched up volume of 17.11 lakh shares by 14:14 IST on NSE, a 11.8 fold spurt over two-week average daily volume of 1.45 lakh shares

Volumes spurt at FDC Ltd counter

Shares of Wockhardt hit a multi-year high of Rs 943.20, zooming 65 per cent in past nine trading days.

Pharma shares shine; Dr Reddy’s, FDC, Glenmark, Suven trade at record highs

The latest directive requires manufacturers to label their products with the warning that the “FDC (fixed-drug combination) should not be used in children below 4 years of age”

Govt bans anti-cold drug combination for kids aged under four

The the Subject Expert Committee of the Central Drugs Standard Control Organisation recommended a precautionary measure, suggesting that the FDC should not be administered to children below 4 years

Drug regulator issues warning against cold medication for children under 4 yrs

Commercial production to commence in the third quarter of FY24

Aurobindo Pharma’s generic FDC drug to treat children living with HIV gets U.S. FDA’s tentative nod

FDC’s June quarter profit rose 55% YoY to Rs 109.81 crore, and its board approved buyback of shares worth Rs 155 crore.

FDC Stock Hits Record High After Q1 Profit Jumps, Board Approves Share Buyback

The government banned 14 FDCs in June that affected around Rs 824 crore of the domestic pharmaceuticals market

FDC Ban Latest News: Govt planning more crackdowns on vitamin and mineral combination drugs

The BSE Healthcare index has reversed its downtrend and is on track for a potential rally. Positive chart indicators and strong support levels suggest a bullish outlook. Consider long-term opportunities in healthcare stocks like Aurobindo Pharma, Zydus Lifesciences, Natco Pharma, FDC, and Jubilant P…

Chart Focus: BSE Healthcare Index Shows Bullish Reversal, Points to Potential Rally

The government had announced a ban on 14 FDC drugs on June 2 this year on the recommendations of an expert committee, saying there was ”no therapeutic justification” for these medicines

Delhi HC Seeks Centre’s Stand on Challenge to Ban on Fixed Dose Combination Drugs - News18

Sectorally, buying was seen in realty, IT, telecom, oil & gas, and energy stocks, while some selling was seen in capital goods and power stocks. ​Stocks in focus included names like FDC, which hit a fresh 52-week high, Suzlon, which rallied over 9% and Go Fashion, which fell nearly 5% on Monday.

Breakout Stocks: How are FDC, Suzlon Energy and Go Fashion looking on charts for Tuesday

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

FDC Limited is a pharmaceutical company  engaged in manufacture of specialized formulations, and oral rehydration salts (ORS). Its brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.

F D C Ltd